Restoration of T-cell function in HIV infection by reduction of intracellular cAMP levels with adenosine analogues

AIDS

Volumn 7, Issue 5, 1993, Pages 659-664

  Hofmann, Bo ^a,b   Nishanian, Parunag ^a   Nguyen, Thang ^a   Liu, Min ^a   Fahey, John L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

cAMP; Dideoxyadenosine; HIV infection; Protein kinase A; Restoration of T cell function; T cell function

Indexed keywords

2',5' DIDEOXYADENOSINE; ADENOSINE DERIVATIVE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CELLULAR IMMUNODEFICIENCY; CLONAL ANERGY; CYTOTOXICITY; ENZYME ACTIVITY; ETIOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ADENOSINE; AMINO ACID SEQUENCE; ANTIGENS, FUNGAL; CANDIDA ALBICANS; CYCLIC AMP; DIDEOXYADENOSINE; HIV INFECTIONS; HUMAN; IN VITRO; INTRACELLULAR FLUID; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PROTEIN KINASES; SUBSTRATE SPECIFICITY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES;

EID: 0027312867     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199305000-00008     Document Type: Article

References (30)

1. SCHROFF RW, GOTTLIEB MS, PRINCE HE, CHAI LL, FAHEY JL: Immunological studies of homosexual men with immunodeficiency and Kaposi's sarcoma. Clin Immunol Immunopathol 1983, 27:300-314.
2. HOFMANN B, LINDHARDT BO, GERSTOFT J, ET AL.: The lymphocyte transformation response to pokeweed mitogen is a highly predictive parameter for the development of AIDS and AIDS-related symptoms in homosexual men with HIV antibodies. BMJ 1987, 295:293-296.
3. HOFMANN B, JAKOBSEN K, ODUM N, ET AL.: The HIV-induced immunodeficiency: relatively preserved PHA as opposed to decreased PWM response may be due to possibly preserved responses via CD2/PHA pathway. J Immunol 1989, 142:1874-1880.
4. GERSTOFT J, DICKMEISS E, MATHISEN L: Cytotoxic capabilities of lymphocytes from patients with the acquired immunodeficiency syndrome. Scand J Immunol 1985, 22:463-170.
5. HOFMANN B, ODUM N, PLATZ P, RYDER LP, SVEJGAARD A, NIELSEN JO: Immunological studies in AIDS. Functional studies of lymphocyte subpopulations. Scand J Immunol 1985, 21:235-243.
6. ROOK AH, MAZUR H, LANE HC: Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activity of lymphocytes from patients with the acquired immunodeficiency syndrome. J Clin Invest 1983, 72:398-403.
7. HARPER ME, MARSELLE LM, GALLO RC, WONG-STAAL F: Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proc Natl Acad Sci USA 1989, 83:772-776.
8. SCHNITTMAN SM, GREENHOUSE JJ, PSALUDOPOULOS MC, ET AL.: Increasing viral burden in CD4+ T cells from patients with HIV infection reflects rapidly progressive immunosuppression and clinical disease. Ann Intern Med 1990, 113:438-443.
9. PATEL MD, SAMELSON LE, KLAUSNER RD: Multiple kinases and signal transduction. J Biol Chem 1987, 262:5831-5838.
10. KAMMER GM: The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol Today 1988, 9:222-229.
11. TAKAYAMA H, TRENN G, SITKOVSKY MV: Locus of inhibitory action of cAMP-dependent protein kinases in the antigen receptor-triggered cytotoxic T-lymphocyte activation pathway. J Biol Chem 1988, 263:2330-2336.
12. LINGK DS, CHAN MA, GELFAND EW: Increased cAMP levels block progression but not initiation of human T-cell proliferation. J Immunol 1990, 145:449-455.
13. YONG-HE Z, NAI-KI M, KOK-NAM L, HUNT NH: Modulation of T cells by cAMP in murine influenza virus infection. I. In vitro inhibition of cytotoxic T lymphocytes by exogenous cAMP analogues and by agents which increase intracellular cAMP concentrations. Immunopharmacology 1987, 13:37-45.
14. NOKTA M, POLLARD R: Human immunodeficiency virus infection: association with altered intracellular levels of cAMP and cGMP in MT-4 cells. Virology 1991, 181:211-217.
15. HOFMANN B, NISHANIAN P, BALDWIN RL, INSIXIENGMAY P, NELL A, FAHEY JL: HIV inhibits the early steps of lymphocyte activation, including initiation of inositol phospholipid metabolism. J Immunol 1990, 145:3699-3705.
16. HOFMANN B, NISHANIAN P, NGUYEN T, INSIXIENGMAY P, FAHEY JL: HIV proteins induce the inhibitory cAMP/protein kinase A pathway in normal T lymphocytes. Proc Natl Acad Sci USA 1993 (in press).
17. DETELS R, ENGLISH PA, GIORGI JV, ET AL.: Patterns of CD4+ cell changes after HIV-1 infection indicate the existence of a codeterminant of AIDS. J Acquir Immune Defic Syndr 1988, 1:390-395.
18. KEMP BE, GRAVES DJ, BENJAMINI E, KREBS EG: Role of multiple basic residues in determining the substrate specificity and cyclic AMP-dependent protein kinase. J Biol Chem 1977, 252:4888-4893.
19. KEMP BE, CHENG HC, WALSH DA: Peptide inhibitors of cAMP-dependent protein kinase. Methods Enzymol 1988, 159:173-183.
20. JOHNSON RA, SHOSHANI I: Kinetics of 'P'-site-mediated inhibition of adenylyl cyclase and the requirements for substrate. J Biochem Chem 1990, 265:11595-11600.
21. HOFMANN B, ODUM N, PLATZ P, RYDER LP, SVEJGAARD A, NIELSEN JO: Immunological studies in AIDS: functional studies of lymphocyte subpopulations. Scand J Immunol 1985, 21:235-243.
22. NEL AE, WOOTEN MW, GALBRAITH RM: Molecular signaling mechanisms in T-lymphocyte activation pathways: a review and future prospects. Clin Immunol Immunopathol 1987, 44:167-186.
23. 2 and other cAMP-elevating agents modulate IL-2 and IL-12R-alpha gene expression at multiple levels. J Immunol 1992, 148:2845-2852.
24. MITZEL SB: cAMP and IL-1 signal transduction. Immunol Today 1990, 11:390-391.
25. 2 by monocytes from drug addicts with AIDS. AIDS 1989, 3:91-96.
26. ENG C, GERSTOFT J, MOLLER S, REMVIG L: Interleukin-1 activity in AIDS. Scand J Immunol 1986, 23:491-497.
27. HOFMANN B, ODUM N, FUGGER L, ET AL.: Immunological studies in AIDS: the effect of TCGF and indomethacin on the in vitro lymphocyte response. Cancer Detect Prev 1987, (suppl 1):619-626.
28. 2-microglobulin level increases in HIV infection: relation to seroconversion, CD4 T-cell fall and prognosis. AIDS 1990, 4:207-214.
29. FAHEY JL, TAYLOR J, DETELS R, ET AL.: The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med 1990, 322:166-172.
30. MITSUYA H, YARCHOAN R, BRODER S: Molecular targets for AIDS therapy. Science 1990, 249:1533-1544.